Cargando…

Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia

BACKGROUND: Cases of refractory Mycoplasma pneumoniae pneumonia have been increasing recently; however, whether viral coinfection or macrolide-resistant M. infection contribute to the development of refractory M. pneumoniae pneumonia remains unclear. This study aimed to investigate the impacts of vi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yajuan, Wang, Jing, Chen, Wenjuan, Shen, Nan, Tao, Yue, Zhao, Ruike, Luo, Lijuan, Li, Biru, Cao, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447613/ https://www.ncbi.nlm.nih.gov/pubmed/32847534 http://dx.doi.org/10.1186/s12879-020-05356-1

Ejemplares similares

Construction of a Nomogram for Identifying Refractory Mycoplasma pneumoniae Pneumonia Among Macrolide-Unresponsive Mycoplasma pneumoniae Pneumonia in Children
por: Xie, Qiaoyi, et al.
Publicado: (2022)

A Case of Macrolide-Refractory Mycoplasma pneumoniae Pneumonia in Pregnancy Treated with Garenoxacin
por: Matsuda, Yoko, et al.
Publicado: (2017)

Macrolide-resistant Mycoplasma pneumoniae in children in Taiwan
por: Wu, Han-Meng, et al.
Publicado: (2012)

Drug Resistance Mechanisms of Mycoplasma pneumoniae to Macrolide Antibiotics
por: Liu, Xijie, et al.
Publicado: (2014)

Macrolide-Resistant Mycoplasma pneumoniae, United States
por: Zheng, Xiaotian, et al.
Publicado: (2015)

Macrolide Resistance in Mycoplasma pneumoniae, Israel, 2010
por: Averbuch, Diana, et al.
Publicado: (2011)

Highly homogeneous microbial communities dominated by Mycoplasma pneumoniae instead of increased resistance to macrolide antibiotics is the characteristic of lower respiratory tract microbiome of children with refractory Mycoplasma pneumoniae pneumonia
por: Chen, Jinglong, et al.
Publicado: (2021)

Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia
por: Miyashita, Naoyuki, et al.
Publicado: (2012)

The Efficacy of Glucocorticoid on Macrolide Resistant Mycoplasma Pneumonia in Children
por: Oh, Jae-Won
Publicado: (2014)

Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment
por: Pereyre, Sabine, et al.
Publicado: (2016)

Clinical Characteristics of Macrolide-Refractory Mycoplasma pneumoniae Pneumonia in Korean Children: A Multicenter Retrospective Study
por: Choi, Yun Jung, et al.
Publicado: (2022)

Macrolide-Resistant and Macrolide-Sensitive Mycoplasma pneumoniae Pneumonia in Children Treated Using Early Corticosteroids
por: Han, Hye Young, et al.
Publicado: (2021)

Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia
por: Chen, Yu-Chin, et al.
Publicado: (2020)

Two unexpected phenomena in macrolide-resistant Mycoplasma pneumoniae infection in Japan and the unique biological characteristics of Mycoplasma pneumoniae
por: Narita, Mitsuo
Publicado: (2011)

Megapneumonia Coinfection: pneumococcus, Mycoplasma pneumoniae, and Metapneumovirus
por: Hon, Kam Lun, et al.
Publicado: (2012)

Characteristics of Lung Microbiota in Children's Refractory Mycoplasma pneumoniae Pneumonia Coinfected with Human Adenovirus B
por: Zhou, Wenxiang, et al.
Publicado: (2022)

Human adenovirus Coinfection aggravates the severity of Mycoplasma pneumoniae pneumonia in children
por: Gao, Jiaojiao, et al.
Publicado: (2020)

Impact of Epstein-Barr virus coinfection in Mycoplasma pneumoniae pneumonia
por: Xu, Yingchun, et al.
Publicado: (2020)

Predictive value of C-reactive protein in response to macrolides in children with macrolide-resistant Mycoplasma pneumoniae pneumonia
por: Seo, Young Ho, et al.
Publicado: (2014)

Mycoplasma pneumoniae and Adenovirus Coinfection Cause Pediatric Severe Community-Acquired Pneumonia
por: Li, Fei, et al.
Publicado: (2022)

Additional corticosteroids or alternative antibiotics for the treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia
por: Yang, Eun-Ae, et al.
Publicado: (2017)

Benefits and risks of therapeutic alternatives for macrolide resistant Mycoplasma pneumoniae pneumonia in children
por: Yang, Hyeon-Jong
Publicado: (2019)

Prevalence and clinical manifestations of macrolide resistant Mycoplasma pneumoniae pneumonia in Korean children
por: Lee, Eun, et al.
Publicado: (2017)

Mechanism of resistance acquisition and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children
por: Yang, Hyeon-Jong, et al.
Publicado: (2017)

Clinical Efficacy of Doxycycline for Treatment of Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Children
por: Lee, Hyunju, et al.
Publicado: (2021)

Macrolide Resistance of Mycoplasma pneumoniae, South Korea, 2000–2011
por: Hong, Ki Bae, et al.
Publicado: (2013)

Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008–2015
por: Tanaka, Takaaki, et al.
Publicado: (2017)

Macrolide-Resistant Mycoplasma pneumoniae Infections in Children, Ohio, USA
por: Lanata, Mariana M., et al.
Publicado: (2021)

Characteristics of hospitalized children infected with macrolide-resistant Mycoplasma pneumoniae
por: Komatsu, Haruki, et al.
Publicado: (2014)

Allele-specific real-time PCR testing for minor macrolide-resistant Mycoplasma Pneumoniae
por: Guo, Dongxing, et al.
Publicado: (2019)

Macrolide versus Non-Macrolide in Combination with Steroids for the Treatment of Lobar or Segmental Mycoplasma pneumoniae Pneumonia Unresponsive to Initial Macrolide Monotherapy
por: Bae, Eunha, et al.
Publicado: (2022)

Viral and bacterial co-infection in hospitalised children with refractory Mycoplasma pneumoniae pneumonia
por: Zhang, Xinxing, et al.
Publicado: (2018)

Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis
por: Ahn, Jong Gyun, et al.
Publicado: (2021)

Clinical significance of respiratory virus coinfection in children with Mycoplasma pneumoniae pneumonia
por: Choo, Soojeong, et al.
Publicado: (2022)

Epidemiology of Mycoplasma pneumoniae Infections in Japan and Therapeutic Strategies for Macrolide-Resistant M. pneumoniae
por: Yamazaki, Tsutomu, et al.
Publicado: (2016)

First Description of Macrolide-Resistant Mycoplasma pneumoniae in Adults with Community-Acquired Pneumonia in Italy
por: Loconsole, Daniela, et al.
Publicado: (2019)

Case Report: Omadacycline in the treatment of macrolide-unresponsive Mycoplasma pneumoniae pneumonia in an adolescent patient
por: Xu, Limin, et al.
Publicado: (2023)

1325. Macrolide versus Non-macrolide in Combination with Steroids for the Treatment of Lobar or Segmental Mycoplasma Pneumoniae Pneumonia Unresponsive to Initial Macrolide Monotherapy
por: Bae, Eunha, et al.
Publicado: (2022)

Consideration in treatment decisions for refractory Mycoplasma pneumoniae pneumonia
por: Cho, Hye-Kyung
Publicado: (2021)

Development of a Nomogram for Predicting Refractory Mycoplasma pneumoniae Pneumonia in Children
por: Shen, Fangfang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1v6knoaeup113c6l8cibqjh20i